RETeval All Comers Trial (REACT)

NAUnknownINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Retinal Disease, Electroretinogram
Interventions
DEVICE

RETeval

The RETeval device measures the retina's electrical response to light, called an electroretinogram (ERG). The standards body ISCEV \[1\] recommends collecting normative data for ERGs to provide waveforms and statistically relevant measurements representing the range of ERGs from people with normal vision. LKC Technologies provides this information with their UTAS product line and wishes to collect such a database for the newest device: the RETeval device. As the RETeval device uses a different electrode to measure the ERG, the normal data for the UTAS product line is not transferable to the RETeval device. Ophthalmic practitioners would also like ERG examples of specific retinal disorders to help diagnose patients with abnormal ERGs. The RETeval device is FDA cleared (K142567),

Trial Locations (1)

72205

Little Rock Eye Clinic, Little Rock

Sponsors
All Listed Sponsors
lead

LKC Technologies, Inc.

INDUSTRY

NCT03065881 - RETeval All Comers Trial (REACT) | Biotech Hunter | Biotech Hunter